WHAT DOES OXYGEN IV TREATMENT MEAN?

Watch Full Prescribing Details OPDIVO® (nivolumab) is indicated for that treatment of Grownup patients with classical Hodgkin lymphoma (cHL) that has relapsed or progressed immediately after autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin or immediately after 3 or even more lines of systemic therapy that includes